ELITE-Symphony
2007
Efficacy Limiting Toxicity Elimination — Symphony Study
In 1,645 kidney-transplant recipients, low-dose tacrolimus with mycophenolate and steroids gave better graft function than the other immunosuppressive regimens.
Result
Primary endpoint: eGFR at 12 months
Low-dose tacrolimus 65.4 mL/min (superior; p<0.001); biopsy-proven rejection 12.3% and graft survival 94.2%.
- Subtopic
- Immunosuppression
- Design
- Open-label RCT, four arms
- Relevance
- Practice-defining: a trial the field needs to know.
- Source
- Ekberg H, et al. N Engl J Med. 2007;357(25):2562-2575.doi 10.1056/NEJMoa067411
Discussion & critique
Established low-dose tacrolimus plus mycophenolate and steroids as the de-novo standard.